1466 — Baijin Life Science Holdings Cashflow Statement

0.000.00%

Last trade - 00:00

Consumer CyclicalsHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Baijin Life Science Holdings, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-52.1	-15.5	8.73	-8.53	-1.36
Depreciation
Amortisation
Non-Cash Items	39.1	11.1	-30.3	-14.8	-1.46
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-5.39	4.15	-1.4	15	-34.4
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-16.2	1.11	-21.5	-6.46	-30.5
Capital Expenditures	-0.025	-0.046	-0.026	-0.179	-2.44
Purchase of Fixed Assets
Other Investing Cash Flow Items	0.163	-0.014	35.3	4.92	1.6
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	0.138	-0.06	35.3	4.74	-0.846
Financing Cash Flow Items	-5.65	-3.55	-0.067	-0.037	-0.966
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	6.77	-1.72	3.7	0.819	41.4
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-10.1	-0.839	17.7	-3.38	9.89